Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways

Human Molecular Genetics

Volumn 18, Issue 19, 2009, Pages 3696-3707

  Gonçalves, Vânia ^a   Matos, Paulo ^a   Jordan, Peter ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; RAC1 PROTEIN, HUMAN; RNA BINDING PROTEIN; SFRS1 PROTEIN, HUMAN; SFRS3 PROTEIN, HUMAN; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; RAC1 GTP-BINDING PROTEIN; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 70350782482     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp317     Document Type: Article

References (69)

1. Modrek, B. and Lee, C. (2002) A genomic view of alternative splicing. Nat. Genet., 30, 13-19.
2. Blencowe, B.J. (2006) Alternative splicing: new insights from global analyses. Cell, 126, 37-47.
3. Ben-Dov, C., Hartmann, B., Lundgren, J. and Valcárcel, J. (2008) Genome-wide analysis of alternative pre-mRNA splicing. J. Biol. Chem., 283, 1229-1233.
4. Romero, P.R., Zaidi, S., Fang, Y.Y., Uversky, V.N., Radivojac, P., Oldfield, C.J., Cortese, M.S., Sickmeier, M., LeGall, T., Obradovic, Z. and Dunker, A.K. (2006) Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc. Natl Acad. Sci. USA, 103, 8390-8395.
5. Schwerk, C. and Schulze-Osthoff, K. (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell, 19, 1-13.
6. Venables, J.P. (2006) Unbalanced alternative splicing and its significance in cancer. BioEssays, 28, 378-386.
7. Srebrow, A. and Kornblihtt, A.R. (2006) The connection between splicing and cancer. J. Cell Sci., 119, 2635-2641.
8. Wennerberg, K. and Der, C.J. (2004) Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci., 117, 1301-1312.
9. Jaffe, A.B. and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu. Rev. Cell. Dev. Biol., 21, 247-269.
10. Sahai, E. and Marshall, C.J. (2002) Rho-GTPases and cancer. Nat. Rev. Cancer, 2, 133-142.
11. Jordan, P., Brazão, R., Boavida, M.G., Gespach, C. and Chastre, E. (1996) In vivo evidence that TATA-binding protein/SL1 colocalizes with UBF and RNA polymerase I when rRNA synthesis is either active or inactive. J. Cell Biol., 133, 225-234.
12. Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Schmitt, M. and Lengyel, E. (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterisation of a new isoform, Rac1b. Oncogene, 19, 3013-3020.
13. Matos, P., Skaug, J., Marques, B., Beck, S., Veríssimo, F., Gespach, C., Boavida, M.G., Scherer, S.W. and Jordan, P. (2000) Small GTPase Rac1: structure, localisation and expression of the human gene. Biochem. Biophys. Res. Commun., 277, 741-751.
14. Matos, P., Collard, J.G. and Jordan, P. (2003) Tumor-related alternative-spliced Rac1b is not regulated by Rho-GDI and exhibits selective downstream signaling. J. Biol. Chem., 278, 50442-50448.
15. Fiegen, D., Haeusler, L.C., Blumenstein, L., Herbrand, U., Dvorsky, R., Vetter, I.R. and Ahmadian, M.R. (2004) Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem., 279, 4743-4749.
16. Singh, A., Karnoub, A.E., Palmby, T.R., Lengyel, E., Sondek, J. and Der, J.C. (2004) Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene, 23, 9369-9380.
17. Radisky, D.C., Levy, D.D., Littlepage, L.E., Liu, H., Nelson, C.M., Fata, J.E., Leake, D., Godden, E.L., Albertson, D.G., Nieto, M.A. et al. (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127.
18. Matos, P. and Jordan, P. (2005) Expression of Rac1b stimulates NF-kB-mediated cell survival and G1/S-progression. Exp. Cell Res., 305, 292-299.
19. Matos, P. and Jordan, P. (2006) RAC1, but not RAC1B, stimulates RELB-mediated gene transcription in colorectal cancer cells. J. Biol. Chem., 281, 13724-13732.
20. Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C. and Strauss, M. (1999) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol., 19, 2690-2698.
21. Guttridge, D.C., Albanese, C., Reuther, J.Y., Pestell, R.G. and Baldwin, A.S. Jr (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol., 19, 5785-5799.
22. Perona, R., Montaner, S., Saniger, L., Sanchez-Perez, I., Bravo, R. and Lacal, J.C. (1997) Activation of the nuclear factor-kappaB by Rho, CDC42 and Rac-1 proteins. Genes Dev., 11, 463-475.
23. Joyce, D., Bouzahzah, B., Fu, M., Albanese, C., D'Amico, M., Steer, J., Klein, J.U., Lee, R.J., Segall, J.E., Westwick, J.K. et al. (1999) Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem., 274, 25245-25249.
24. Esufali, S., Charames, G.S., Pethe, V.V., Buongiorno, P. and Bapat, B. (2007) Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer Res., 67, 2469-2479.
25. Matos, P. and Jordan, P. (2008) Increased Rac1b expression sustains colorectal tumor cell survival. Mol. Cancer Res., 6, 1178-1184.
26. Matos, P., Oliveira, C., Velho, S., Gonçalves, V., da Costa, L.T., Moyer, M.P., Seruca, R. and Jordan, P. (2008) B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology, 135, 899-906.
27. Eperon, I.C., Makarova, O.V., Mayeda, A., Munroe, S.H., Cáceres, J.F., Hayward, D.G. and Krainer, A.R. (2000) Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol., 20, 8303-8318.
28. Smith, C.W. and Valcárcel, J. (2000) Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci., 25, 381-388.
29. Singh, R. and Valcárcel, J. (2005) Building specificity with nonspecific RNA-binding proteins. Nat. Struct. Mol. Biol., 12, 645-653.
30. Ghigna, C., Moroni, M., Porta, C., Riva, S. and Biamonti, G. (1998) Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res., 58, 5818-5824.
31. Stickeler, E., Kittrell, F., Medina, D. and Berget, S.M. (1999) Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene, 18, 3574-3582.
32. Venables, J.P. (2004) Aberrant and alternative splicing in cancer. Cancer Res., 64, 7647-7654.
33. Shin, C. and Manley, J.L. (2004) Cell signaling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell. Biol., 5, 727-738.
34. Blaustein, M., Pelisch, F. and Srebrow, A. (2007) Signals, pathways and splicing regulation. Int. J. Biochem. Cell. Biol., 39, 2031-2048.
35. Stamm, S. (2008) Regulation of alternative splicing by reversible protein phosphorylation. J. Biol. Chem., 283, 1223-1227.
36. van der Houven van Oordt, W., Diaz-Meco, M.T., Lozano, J., Krainer, A.R., Moscat, J. and Cáceres, J.F. (2000) The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol., 149, 307-316.
37. Patel, N.A., Kaneko, S., Apostolatos, H.S., Bae, S.S., Watson, J.E., Davidowitz, K., Chappell, D.S., Birnbaum, M.J., Cheng, J.Q. and Cooper, D.R. (2005) Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase C beta II alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J. Biol. Chem., 280, 14302-14309.
38. Jiang, K., Patel, N.A., Watson, J.E., Apostolatos, H., Kleiman, E., Hanson, O., Hagiwara, M. and Cooper, D.R. (2008) Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCssII mRNA. Endocrinology, 150, 2087-2097.
39. Blaustein, M., Pelisch, F., Coso, O.A., Bissell, M.J., Kornblihtt, A.R. and Srebrow, A. (2004) Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J. Biol. Chem., 279, 21029-21037.
40. Spellman, R., Rideau, A., Matlin, A., Gooding, C., Robinson, F., McGlincy, N., Grellscheid, S.N., Southby, J., Wollerton, M. and Smith, C.W. (2005) Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans., 33, 457-460.
41. Förch, P., Puig, O., Kedersha, N., Martínez, C., Granneman, S., Séraphin, B., Anderson, P. and Valcárcel, J. (2000) The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell, 6, 1089-1098.
42. Cavaloc, Y., Bourgeois, C.F., Kister, L. and Stévenin, J. (1999) The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA, 5, 468-483.
43. Huang, Y. and Steitz, J.A. (2001) Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol. Cell, 7, 899-905.
44. Cartegni, L., Wang, J., Zhu, Z., Zhang, M.Q. and Krainer, A.R. (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res., 31, 3568-3571.
45. Stamm, S., Riethoven, J.J., Le Texier, V., Gopalakrishnan, C., Kumanduri, V., Tang, Y., Barbosa-Morais, N.L. and Thanaraj, T.A. (2006) ASD: a bioinformatics resource on alternative splicing. (Database issue). Nucleic Acids Res., 34, D46-D55.
46. Fairbrother, W.G., Yeh, R.F., Sharp, P.A. and Burge, C.B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science, 297, 1007-1013.
47. Wang, Z., Rolish, M.E., Yeo, G., Tung, V., Mawson, M. and Burge, C.B. (2004) Systematic identification and analysis of exonic splicing silencers. Cell, 119, 831-845.
48. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
49. Gonçalves, V., Matos, P. and Jordan, P. (2008) The b-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression. RNA, 14, 2538-2549.
50. Carmel, I., Tal, S., Vig, I. and Ast, G. (2004) Comparative analysis detects dependencies among the 5' splice-site positions. RNA, 10, 828-840.
51. Jumaa, H. and Nielsen, P.J. (1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J., 16, 5077-5085.
52. Mayeda, A., Helfman, D.M. and Krainer, A.R. (1993) Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol., 13, 2993-3001.
53. Galiana-Arnoux, D., Lejeune, F., Gesnel, M.C., Stevenin, J., Breathnach, R. and Del Gatto-Konczak, F. (2003) The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J. Biol. Chem., 278, 32943-32953.
54. Xiao, S.H. and Manley, J.L. (1997) Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev., 11, 334-344.
55. Sanford, J.R., Ellis, J.D., Cazalla, D. and Cáceres, J.F. (2005) Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc. Natl Acad. Sci. USA, 102, 15042-15047.
56. Blaustein, M., Pelisch, F., Tanos, T., Muñoz, M.J., Wengier, D., Quadrana, L., Sanford, J.R., Muschietti, J.P., Kornblihtt, A.R., Cáceres, J.F. et al. (2005) Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol., 12, 1037-1044.
57. Pelisch, F., Blaustein, M., Kornblihtt, A.R. and Srebrow, A. (2005) Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J. Biol. Chem., 280, 25461-25469.
58. Patel, N.A., Chalfant, C.E., Watson, J.E., Wyatt, J.R., Dean, N.M., Eichler, D.C. and Cooper, D.R. (2001) Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. J. Biol. Chem., 276, 22648-22654.
59. Gui, J.F., Lane, W.S. and Fu, X.D. (1994) A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature, 369, 678-682.
60. Qiu, R.G., Chen, J., Kirn, D., McCormick, F. and Symons, M. (1995) An essential role for Rac in Ras transformation. Nature, 374, 457-459.
61. Gama-Carvalho, M., Krauss, R.D., Chiang, L., Valcarcel, J., Green, M.R. and Carmo-Fonseca, M. (1997) Targeting of U2AF65 to sites of active splicing in the nucleus. J. Cell Biol., 137, 975-987.
62. Pacheco, T.R., Coelho, M.B., Desterro, J.M., Mollet, I. and Carmo- Fonseca, M. (2006) In vivo requirement of the small subunit of U2AF for recognition of a weak 3' splice site. Mol. Cell Biol., 26, 8183-8190.
63. Matter, N., Marx, M., Weg-Remers, S., Ponta, H., Herrlich, P. and König, H. (2000) Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J. Biol. Chem., 275, 35353-35360.
64. Cáceres, J.F., Misteli, T., Screaton, G.R., Spector, D.L. and Krainer, A.R. (1997) Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J. Cell Biol., 138, 225-238.
65. Huang, H., Cheville, J.C., Pan, Y., Roche, P.C., Schmidt, L.J. and Tindall, D.J. (2001) PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J. Biol. Chem., 276, 38830-38836.
66. Burgering, B.M. and Coffer, P.J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 376, 599-602.
67. Ludwig, S., Hoffmeyer, A., Goebeler, M., Kilian, K., Häfner, H., Neufeld, B., Han, J. and Rapp, U.R. (1998) The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem., 273, 1917-1922.
68. Rennefahrt, U.E., Illert, B., Kerkhoff, E., Troppmair, J. and Rapp, U.R. (2002) Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype. J. Biol. Chem., 277, 29510-29518.
69. Wadman, I.A., Osada, H., Grü tz, G.G., Agulnick, A.D., Westphal, H., Forster, A. and Rabbitts, T.H. (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J., 16, 3145-3157.